Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Topics

Select Topic

Showing 1,267 results.

Thumbnail for Accelerated Biological Ageing Amplifies the Association Between Dietary Advanced Glycation End-Products and Hematologic Malignancy Prevalence: A U.S. Population-Based Study

AML - 1751

Accelerated Biological Ageing Amplifies the Association Between Dietary Advanced Glycation End-Products and Hematologic Malignancy Prevalence: A U.S. Population-Based Study

Kashish Magnani

Poster Presenter: Kashish Magnani

Thumbnail for Preventable Leukemia in the Workplace: Global Burden of Occupational Benzene-Attributable Leukemia, 1990-2023

AML - 1755

Preventable Leukemia in the Workplace: Global Burden of Occupational Benzene-Attributable Leukemia, 1990-2023

Hardik Jain

Poster Presenter: Hardik Jain

Previous 1...32 33 34 35 36 37 38...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Impact of Time to Chemotherapy Initiation on Overall Survival in Acute Myeloid Leukemia: A National Cancer Database Analysis

AML - 193

Impact of Time to Chemotherapy Initiation on Overall Survival in Acute Myeloid Leukemia: A National Cancer Database Analysis

Yazmin Reategui Almonacid

Poster Presenter: Yazmin Reategui Almonacid

Thumbnail for Treatment Response and Survival Outcomes of Venetoclax Plus Hypomethylating Agents vs Hypomethylating Agents Alone in Elderly AML: A Systematic Review and Meta-Analysis of Clinical Trial and Real-World Evidence

AML - 205

Treatment Response and Survival Outcomes of Venetoclax Plus Hypomethylating Agents vs Hypomethylating Agents Alone in Elderly AML: A Systematic Review and Meta-Analysis of Clinical Trial and Real-World Evidence

Mohammad Hamza Bin Abdul Malik

Poster Presenter: Mohammad Hamza Bin Abdul Malik

AML - 208

Profile and Treatment Outcomes of Filipino Acute Myeloid Leukemia Patients Managed at a Tertiary Institution: A Single-Center, 10-Year Retrospective Study

Roanne Ilano

Poster Presenter: Roanne Ilano

Thumbnail for Comprehensive Genomic Profiling of Myeloid Neoplasms: Integrating NGS, Cytogenetics, and FISH for Risk Stratification

AML - 219

Comprehensive Genomic Profiling of Myeloid Neoplasms: Integrating NGS, Cytogenetics, and FISH for Risk Stratification

Zeeshan Ansar Ahmed

Poster Presenter: Zeeshan Ansar Ahmed

Thumbnail for Global Inequities in Leukemia Survival Persist Despite Overall Gains: GBD 2023 MIR Trends, 1990-2023

AML - 222

Global Inequities in Leukemia Survival Persist Despite Overall Gains: GBD 2023 MIR Trends, 1990-2023

Tapan Giri

Poster Presenter: Tapan Giri

Thumbnail for Transfer-Pathway Vulnerability, Not Final Hospital Type, Defines Early Mortality Risk in Acute Promyelocytic Leukemia: National NIS/NRD Data, 2016-2022

AML - 252

Transfer-Pathway Vulnerability, Not Final Hospital Type, Defines Early Mortality Risk in Acute Promyelocytic Leukemia: National NIS/NRD Data, 2016-2022

Woo Joo Lee

Poster Presenter: Woo Joo Lee

Thumbnail for “EASIX Score Predicts Severe Acute GVHD and Mortality After Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Study"

AML - 256

“EASIX Score Predicts Severe Acute GVHD and Mortality After Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Study"

Juliana Faleschini

Poster Presenter: Juliana Faleschini

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors